The acquisition bolsters Boehringer's immuno-oncology pipeline with Nerio's new PTPN2/N1 [protein tyrosine phosphatase ...

focusing on compounds that target protein tyrosine phosphatases N1 and N2 (PTPN1 and PTPN2). According to Nerio, inhibiting these enzymes can disrupt a tumour's ability to evade the immune system ...

Study: Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 Gene. Image Credit: GB.JSTOCK / Shutterstock.com A recent study published ...